Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05036_nanopub.RAC7CcuRAIkanpvC1XxMvD6-sziSj9jkvHYGbFLDTGOsk#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05036 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05036 label "Grn163l [drugbank:DB05036]" assertion.
- drugbank:DB05036 seeAlso DB05036 assertion.
- drugbank:DB05036 description "GRN163L is a novel anti-cancer drug. It has been characterized preclinically and shown to inhibit telomerase in human tumor cells of many cancer types (including lung, breast, prostate, liver, and early stage of human breast cancer), in both cell culture systems and animal models. Study of this drug shows the its potential utility in the treatment of patients with hematologic and solid tumor malignancies." assertion.
- drugbank:DB05036 identifier "drugbank:DB05036" assertion.
- drugbank:DB05036 title "Grn163l" assertion.
- drugbank:DB05036 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05036 drugbank_vocabulary:drugbank-id "DB05036" assertion.
- drugbank:DB05036 bio2rdf_vocabulary:x-identifiers.org DB05036 assertion.
- drugbank:DB05036 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05036" assertion.
- drugbank:DB05036 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05036 bio2rdf_vocabulary:identifier "DB05036" assertion.